학술논문
The Radiosurgery Society Case-Based Discussion of the Management of Head and Neck or Skull Base Paragangliomas with Stereotactic Radiosurgery and Radiotherapy.
Document Type
Academic Journal
Author
Ehret F; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Radiation Oncology, Berlin, Germany; Charité - Universitätsmedizin Berlin, Berlin, Germany; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany; European Radiosurgery Center Munich, Munich, Germany. Electronic address: felix.ehret@charite.de.; Ebner DK; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota.; McComas KN; Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.; Gogineni E; Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, Ohio.; Andraos T; Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, Ohio.; Kim M; Department of Radiation Oncology, University of Washington School of Medicine, Seattle, Washington.; Lo S; Department of Radiation Oncology, University of Washington School of Medicine, Seattle, Washington.; Schulder M; Department of Neurosurgery, Zucker School of Medicine at Hofstra/Northwell, New York, New York.; Redmond KJ; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, Maryland.; Muacevic A; European Radiosurgery Center Munich, Munich, Germany.; Shih HA; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.; Kresl J; Radiation Oncology and Radiosurgery, Phoenix CyberKnife & Radiation Oncology Center, Phoenix, Arizona.
Source
Publisher: Elsevier Country of Publication: United States NLM ID: 101558279 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-8519 (Electronic) Linking ISSN: 18798500 NLM ISO Abbreviation: Pract Radiat Oncol Subsets: MEDLINE
Subject
Language
English
Abstract
Stereotactic radiosurgery (SRS) and fractionated stereotactic radiotherapy (FSRT) have been used for the treatment of head and neck or skull base paraganglioma for a considerable time, demonstrating promising local control rates and a favorable safety profile compared with surgical approaches. Nevertheless, the choice of treatment must be carefully tailored to each patient's preferences, tumor location, and size, as well as anticipated treatment-related morbidity. This case-based review serves as a practical and concise guide for the use of SRS and FSRT in the management of head and neck or skull base paragangliomas, providing information on the diagnosis, treatment, follow-up considerations, and potential pitfalls.
Competing Interests: Disclosures Felix Ehret reports honoraria and travel support from ZAP Surgical Systems, Inc. Simon Lo reports research funding or travel support from the Japanese Society for Radiation Oncology (JASTRO), Kuni Foundation, and Hutchinson Center. Michael Schulder reports participation on the DSMB for the NIH and Alpheus, Inc., and stock ownership of Hyperfine, Inc. Kristin Redmond reports research funding, honoraria, or travel support from Accuray, Inc., Canon, Elekta AB, AAPM, the RSS, participation on the DSMB for BioMimetix, and has a patent on radiogenomics pending. Alexander Muacevic reports honoraria and travel support from ZAP Surgical Systems, Inc. and is an AERO board member.
(Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)
Competing Interests: Disclosures Felix Ehret reports honoraria and travel support from ZAP Surgical Systems, Inc. Simon Lo reports research funding or travel support from the Japanese Society for Radiation Oncology (JASTRO), Kuni Foundation, and Hutchinson Center. Michael Schulder reports participation on the DSMB for the NIH and Alpheus, Inc., and stock ownership of Hyperfine, Inc. Kristin Redmond reports research funding, honoraria, or travel support from Accuray, Inc., Canon, Elekta AB, AAPM, the RSS, participation on the DSMB for BioMimetix, and has a patent on radiogenomics pending. Alexander Muacevic reports honoraria and travel support from ZAP Surgical Systems, Inc. and is an AERO board member.
(Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)